International Workshop PSD-11 Delft. Clive Naidoo (PhD Chemistry) Dept Head: Radionuclide Production ithemba LABS South Africa

Similar documents
Recent Developments and Proposed Applications with the Accelerators at ithemba LABS

Update from Karolinska

Refurbishment of the Electrostatic Accelerators of ithemba LABS

[ 11 C]NNC 112 FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

[ 11 C]MePPEP FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

Radiotracers for Early Diagnosis - ReSearching for a Better Life!

Best MeV. Best , 25 MeV

Isotope Production at High Energy Leonard Mausner

Travels with a Cyclotron. David Parker University of Birmingham

State Atomic Energy Corporation Rosatom Russian Radiation Technologies: opportunities to success

Applications for Industry and Environment. Radioisotope and Radiation Technology. International Atomic Energy Agency

PANEL DISCUSSION. Radionuclides and Health A promising future! OCTOBER 14-16, 2014 PARIS LE BOURGET FRANCE

Measurement of induced radioactivity in air and water for medical accelerators

CLINICALLY USEFUL RADIONUCLIDES:

Krotov S.A., postgraduate student, Institute of chemistry SPbSU, Radiochemical Department

Project of RIC-80 facility at PNPI for medical isotope production

Isotope Production for Nuclear Medicine

EBSS: Hands-on Activity #8. Operation of an electromagnetic isotope separator (EMIS) Dan Stracener Jon Batchelder

Isotope Production at Brookhaven National Laboratory. Leonard F. Mausner, Brookhaven National Laboratory, Upton, NY. Introduction

THE PURIFICATION AND THE QUALITY CONTROL OF 68 Ga ELUATES FROM 68 Ge/ 68 Ga GENERATOR *

III. Proton-therapytherapy. Rome SB - 2/5 1

Year 12 Notes Radioactivity 1/5

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy

TKI CU01 V-1.0_EN Cu separation from irradiated targets 01/12/10

Towards. sharing the vision shaping the future with SAIF (South African isotopes Facility) Faiçal Azaiez

TRIUMF TR13. Date form last updated: 2016 May 29. Completed by: David Prevost. 1. Cyclotron Facility Contact info. Institute (name/address):

PRODUCTION OF RADIOISOTOPES FOR IMAGING AND THERAPY AT LOW ENERGY

Nuclear Radiation. Natural Radioactivity. A person working with radioisotopes wears protective clothing and gloves and stands behind a shield.

The scanning microbeam PIXE analysis facility at NIRS

Nuclear medicine and Radiation technologies

RPR 29 CYCLOTRON RADIOCHEMISTRY LABORATORY

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009)

OPENING NEW FRONTIERS IN NUCLEAR SCIENCE & APPLICATIONS

AEPHY: Nuclear Physics Practise Test

Introduction to SPECT & PET TBMI02 - Medical Image Analysis 2017

Radiochemistry and Radiopharmacy III

ACETONE IN URINE BY UV CODE Z42010

Radionuclide Production with Cyclotrons 2.0 Proposal for a CHERNE Summer School

Synthesis and stability of [ 77 Br]-m-Bromobenzylguanidine ( 77 Br-MBBG)

Utilization of Egyptian Research Reactor and modes of collaboration

Radiation safety of the Danish Center for Proton Therapy (DCPT) Lars Hjorth Præstegaard Dept. of Medical Physics, Aarhus University Hospital

ChemComm. Supplementary Information. RSCPublishing

[ 18 F]FALLYPRIDE FOR INJECTION: MASTER BATCH RECORD

A. H. Al Rayyes, Atomic Energy Commission of Syria, Chemistry Department, Cyclotron Division, Damascus, Syria

RADIOPHARMACY PURPOSE

Radioisotopes and PET

Operation of the Coupled Cyclotron Facility at Michigan State University

EVOLUTE WCX Columns for Solid Phase Extraction of Quaternary Amines and Strongly Basic Compounds from Aqueous Samples

What is scintigraphy? The process of obtaining an image or series of sequential images of the distribution of a radionuclide in tissues, organs, or

25-OH VITAMIN D 3 IN PLASMA BY UV FAST CODE Z19610

THE IAEA COLLABORATING CENTRE FOR NEUTRON ACTIVATION BASED METHODOLOGIES OF RESEARCH REACTORS

12/18/2016. Radioanalysis Laboratory Capabilities and Issues. Eleventh Annual Radiation Measurement Cross Calibration Workshop RMCC XI

Department of Radiation Protection, Nuclear Science Research Institute, Japan Atomic Energy Agency

Differentiating Chemical Reactions from Nuclear Reactions

The isotope revolution that can change imaging and therapy

Radiation Safety. PIXE PAN 2008 Ed Stech University of Notre Dame

SECTION D.2 AMMONIA NITROGEN

General, Organic, and Biological Chemistry, 3e (Frost) Chapter 2 Atoms and Radioactivity. 2.1 Multiple-Choice

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS

25-OH VITAMIN D 3 AND 25-OH VITAMIN D 2 IN PLASMA BY UV / VIS FAST CODE Z19710

Isotope Production from Compact Neutron Sources. ~ 10 6 n/sec. Danish CANS workshop Mikael Jensen

TARGETS CLAIRE INEZA. submitted in accordance with the requirements for the degree of MASTER OF SCIENCE. In the subject CHEMISTRY.

Activation Products in Proton Therapy

NORBUPRENORPHINE (Buprenorphine s Metabolite ) BUPRENORPHINE in urine by GC/MS Code GC Method of Confirmation by GC-MS

ICTP-IAEA Joint Workshop on Nuclear Data for Science and Technology: Medical Applications. 30 September - 4 October, 2013

RADIOPHARMACEUTICALS

LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator

WM2014 Conference, March 2 6, 2014, Phoenix, Arizona, USA

STATUS REPORT ON SPIRAL1 F. Chautard October 2 nd, 2007

General, Organic, and Biochemistry, 2e (Frost) Chapter 2 Atoms and Radioactivity. 2.1 Multiple-Choice

Experiment 1: The Borohydride Reduction of 9-Fluorenone to 9-Fluorenol

Recent activity of Neutronics related IFMIF

Major Nuclear and Radiation Physics experimental facilities in. Prepared By Dr M Tanseer Ali

Chapter. Nuclear Chemistry

Diquat 1,1 -ethylene-2,2 -bipyridium dibromide salt Paraquat 1,1 -dimethyl-4,4 -bipyridium dichloride salt Initial Preparation

Outline Chapter 14 Nuclear Medicine

Introduction to Accelerator Physics Part 1

Nuclear Research in South Africa and on the African Continent

Radiation protection considerations along a radioactive ion beam transport line

[ 11 C](-)-RWAY FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

Introduction to Accelerator Physics Part 1

LINEAR ACCELERATOR BEAM

KIVI 9 Oct 2015 Fysische Beeldtechnieken 18 feb

Gamma ray coincidence and angular correlation

Production of Fluorine-18 by Small Research Reactor

IAEA-SM-367/10/04/P SCREENING AND RADIOMETRIC MEASUREMENT OF ENVIRONMENTAL SWIPE SAMPLES

ithemba LABS Annual Report 2008

METHOD 8032A ACRYLAMIDE BY GAS CHROMATOGRAPHY

Radiopharmacy quality control

Operating Instructions for Ammonium ISE Specifications

ithemba LABS shaping the future with SAIF : South African Isotope Facility Faiçal Azaiez

ASPARTAME. Not less than 98% and not more than 102% on the dried basis. White, odourless, crystalline powder, having a strong sweet taste

Anion and Cation analysis with Professional IC - automatic dilution and sample preparation with SPM

PRODUCTS FOR EDUCATION AND TRAINING

Role of Radiochemistry in Nuclear Data Research and the Cyclotron Production of Medical Radionuclides

1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI)

accelerating opportunities

*Correspondence to:

Number of protons. 2. What is the nuclear symbol for a radioactive isotope of copper with a mass number of 60? A) Cu

NICKEL-63/59 IN WATER

Transcription:

International Workshop PSD-11 Delft Clive Naidoo (PhD Chemistry) Dept Head: Radionuclide Production ithemba LABS South Africa

ithemba LABS Structure Directorate HR, Finance & General Admin Electronic and Information Services Radionuclide Prod Research Radiation Therapy Accelerator Infrastructure Technical Support & Site Services

RPD OBJECTIVES To produce radiopharmaceuticals for the benefit of the South African Nuclear Medicine community. To produce longer-lived radionuclides for the export market. Research & Development and Training Program.

ithemba LABS Layout Polarized ion source Separated-Sector Cyclotron Facility SSC Target vaults Spectrometer SPC2 ECR ion source SPC1 electronics electronics Radioisotope production Proton therapy Neutron therapy beam swinger 0 10 20 m

Separated Sector Cyclotron (200 MeV)

RPD beam time allocation Monday night 17h00 to 7h00 (14 h) Tuesday night 17h00 to 7h00 (14 h) Wednesday night 17h00 to 7h00 (14 h) Thursday night 17h00 to 5h00 (12 h) On average 54 h / week (32%)

RPD beam time allocation with beam splitter

ithemba LABS Products produced under cgmp principles Radionuclide Half-Life (hours) 18 F 1.83 Nuclear Reaction 15 O(p,n) 18 F 67 Ga 78.3 Zn(p,xn) 67 Ga Ge(p,x) 67 Ga 81 Rb/ 81m Kr 4.58 Kr(p,xn) 81 Rb 123 I 13.2 127 I(p,5n) 123 Xe 123 I 68 Ge/ 68 Ga generator 68 Ge = 271 d 68 Ga = 68 min 69 Ga(p,2n) 68 Ge Radiopharmaceutical Main Use Product 18 F-FDG Glucose metabolic studies 67 Ga-citrate Localization of certain tumours and inflammatory regions 81 Rb/ 81m Kr generator Lung ventilation studies 123 I-sodium iodide Thyroid studies 123 I-mIBG Localization of certain tumours such as neuroblastoma, pheochromocytoma 68 Ga DOTA-peptides Typically detection of neuroendocrine tumours

ithemba LABS other products Radionuclide Half-Life Nuclear Reaction Main Use (days/years) 82 Sr 25 days Rb(p,xn) 82 Sr Used to manufacture 82 Sr/ 82 Rb generators 68 Ge 271 days Ga(p,xn) 68 Ge Used to manufacture 68 Ge/ 68 Ga generators and calibration sources for PET CT scanners 88 Y 106.6 days Sr(p,xn) 88 Y Non medical application calibration sources 109 Cd 453 days Ag(p,xn) 109 Cd Non-medical application-calibration sources 22 Na & Na positron sources 2.602 years Mg(p,n) 22 Na Used in Material Sciences -Positron Annihilation Studies

Horizontal Beam Target Station (HBTS) Produce: 67 Ga, 123 I, 81 Rb, 68 Ge, 82 Sr, 22 Na, 88 Y, 57 Co and 109 Cd HBTS Target and target holders 66 MeV proton beam with an intensity of ~90 µa

Vertical Beam Target Station (VBTS) Produce in Tandem 82 Sr/ 68 Ge and 22 Na/ 68 Ge VBTS Thick Target Holders 66 MeV proton beam with an intensity of ~250 µa VBTS Tandem targets VBTS Tandem targets

18 F- Bombardment Station 18 F Target Station (66 MeV to 18 MeV) Target Control System Enriched water target

Beam Splitter

RPD Control Room Automated Transport System Control systems such as cooling systems (water and helium), interlocking systems and transport system

Chemical Processing Facilities 18 F-Automated Chemical Processing Hot Cells Manual Manipulator Hot Cells (two banks of 7)

3 Independent clean rooms 68 Ge/ 68 Ga 18 F-FDG 123 I / 67 Ga

Dispensing facilitiesnts Comecer Hotcells & Timothea Dispensing Facilities

Quality Control Facilities GC HPLC Capintec Ionisation Chamber

Quality Control Microlab Sterility and endotoxin testing

QC Raw material

Packing and Dispatch As per IATA Regulations

Tandem target for the production of 22 Na and 68 Ge 66 MeV protons 20 mm 65.762 MeV 36.635 MeV 62.579 MeV 61.476 MeV Mg material: 99.99% (15 g) 40.013 MeV 38.444 MeV 36.866 MeV 34.364 MeV 2.364 MeV

Chemical Processing A magnesium target (ca 15 g, 12 mm thick, 20 mm diameter) is bombarded for several weeks with a 66 MeV proton beam at a beam current of 80 μa (in the higher energy window 61.5 40.0 MeV). [Generally production rate is 1 mci / h). The target is dissolved in 3.0 M citric acid and then adjusted to obtain a 0.2 M citric acid - 0.6 M TEA - 80% methanol solution. The solution is pumped through a column containing 10 g of the macroporous cation exchanger AG MP 50. Washing solutions: 0.2 M citric acid - 0.6 M TEA - 80% methanol, followed by 0.1 M EDTA - 0.6 M TEA. The resin is then converted to the ammonium form with 1.0 M ammonia 80% methanol and 22 Na is eluted with 1.0 M ammonium carbonate (100 ml) passing through 10 g of the chelating resin Chelex 100 (in the ammonium form) to remove the last traces of magnesium and other elements. The eluate is heated in a conical titanium vessel to evaporate the ammonia and water. 22 Na is obtained as the carbonate salt in a small volume. All reagents are purified to remove sodium prior to the ion exchange separation Final Specification: >800 Ci 22 Na / g

22 Na Chemical Processing hot cell panel

Capsule Dispensing The specified amount of 22 Na carbonate solution is dispensed from the bulk vial and placed in a V-vial and evaporated to about 20-30 µl. Final activity check is done with the Capintec Ionisation Chamber. The rear part of the capsule is clamped in a holder with the post facing upwards and level. The 22 Na is then transferred, in 10 μl volumes, into the tantalum cup with a semi-automated dispensing apparatus. This is evaporated to incipient dryness, before the next volume is dispensed. When all the activity of 22 Na has been transferred into the cup, the front part of the capsule is loosely screwed onto the rear part. The capsule is finally sealed to a defined torque value (20 Nm) using a special holder to clamp the capsule tightly. The external surface of the capsule is washed with methanol and then rinsed with deionised water. The capsule is dried and a smear test is done. The source is then placed under vacuum for 24 h to ensure integrity of the capsule. The washing step is repeated and another smear test is done after the vacuum test. The positron capsule is then packed into a lead pot, the lead pot is sealed and finally packed in a container for shipment to the user.

Positron Capsule

Dispensing apparatus

Holder to seal the capsule

Apparatus for vacuum testing

HPGe detector for final measurements

Na-22 sales and forecasts

Production Challenges Limited beam time for the irradiation of Mg targets at ithemba LABS. Alternative company s that could produce 22 Na does not meet ithemba LABS product specification of >800 Ci 22 Na / g for large sources. Alternative company s needed to irradiate the Mg target material and for ithemba LABS to do the chemical processing, not economical viable (cost of irradiation US$ 6000 / mci 22 Na). The production of sources is limited to a maximum of 50 mci for the ease of handling and to minimise radiation exposure to staff. NB: Upon receiving the larger sources from ithemba LABS, just do your smear tests as required by your RPO and install.

Thank You For Your Attention clive@tlabs.ac.za